ErinDeanMD

Internal Medicine • Gainesville, FL

Hematology/Oncology

Physician

Join to view full profile

Dr. Dean is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dean's full profile

Already have an account?

Office
UF Health Shands Cancer Hospital
1515 SW Archer Rd
Gainesville, FL 32610
Phone+1 352-733-0972

Fax+1 352-733-1269

Education & Training

University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2017 - 2020
University of South Florida MorsaniResidency, Internal Medicine, 2014 - 2017
University of South Florida College of MedicineClass of 2014

Certifications & Licensure

CA State Medical License 2024 - 2026
FL State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

129 citations
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma
Michael D. Jain, Hua Zhao, Xuefeng Wang, Reginald Atkins, Meghan Menges
Blood. 2021-05-13
18 citations
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Kai Rejeski, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein
Science Advances. 2023-09-22
25 citations
Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophyla...
Farhad Khimani, Peter Ranspach, Hany Elmariah, Jongphil Kim, Junmin Whiting
Transplantation and Cellular Therapy. 2021-11-01

Journal Articles

Central nervous system manifestations as initial presentation of plasma cell disorders: Differential management of 3 cases based on disease extent
Kyle McGrath, Graeme A. Fenton, Robert P. Seifert, Keith R. Peters, John W. Hiemenz, Erin A. Dean, Current Problems in Cancer: Case Reports, 9/2023

Abstracts/Posters

Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-...
Erin Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019